Eli Lilly’s experimental Alzheimer’s drug donanemab on Monday moved a step closer to U.S. regulatory approval as it won support from an independent panel of advisers to the Food and Drug Administration.
Source: https://www.marketwatch.com/story/eli-l ... topstories
Eli Lilly’s Alzheimer’s drug gets backing from FDA advisers
